Doctor profile · Federal record
Dr. Jacqueline Dean, MD
Rheumatology Physician (CMS: Rheumatology) · Albuquerque, NM
- NPI 1184690364
- Accepts Medicare
- MIPS 96.5 / 100 · 2023
- 36 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1617 University Blvd Ne
Albuquerque, NM 871021710
(505) 341-4841
fax (505) 345-9914
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- May 21, 2012
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Mexico #2001-170
- Medicaid
- NM #12737011
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184690364. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
29,238
Distinct HCPCS
10
Medicare allowed
$764,053
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,402 | 24 | $42 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,800 | 12 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 5,991 | 12 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 3,180 | 36 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,635 | 12 | $31 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 398 | 244 | $86 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 171 | 39 | $59 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 138 | 27 | $26 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 137 | 33 | $117 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 124 | 82 | $121 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 2,027. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$294
Transactions
17
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 10 | $132.67 | |
| Amgen Inc. | 3 | $67.45 | |
| PFIZER INC. | 2 | $35.18 | |
| SOBI, INC | 1 | $33.28 | |
| UCB, Inc. | 1 | $25.40 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,724
Patients
625
Total drug cost
$1,223,924
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 389 | 117 | $4,725 |
| Methotrexate (Methotrexate Sodium) | Brand | 382 | 94 | $16,129 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 340 | 62 | $8,824 |
| Hydroxychloroquine Sulfate | Generic | 299 | 89 | $24,057 |
| Oxycodone Hcl | Generic | 224 | 34 | $8,249 |
| Gabapentin | Generic | 211 | 45 | $3,766 |
| Tramadol Hcl | Generic | 131 | 26 | $1,113 |
| Alendronate Sodium | Generic | 120 | 32 | $2,084 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 115 | 31 | $5,550 |
| Morphine Sulfate Er (Morphine Sulfate) | Brand | 99 | 13 | $2,107 |
Frequently asked questions
What is Dr. Jacqueline Dean's medical specialty?
Dr. Jacqueline Dean practices Rheumatology Physician in Albuquerque, NM.
Where does Dr. Jacqueline Dean practice?
Dr. Jacqueline Dean practices at 1617 University Blvd Ne, Albuquerque, NM 871021710. Office phone: 5053414841.
What is Dr. Jacqueline Dean's NPI?
Dr. Jacqueline Dean's National Provider Identifier (NPI) is 1184690364, issued by NPPES.
Does Dr. Jacqueline Dean accept Medicare assignment?
Yes. Dr. Jacqueline Dean accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jacqueline Dean commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.